A. Alimam

Favipiravir for the Treatment of Coronavirus Disease 2019; a propensity score-matched cohort study

K. Shukri, A. Omrani, M. Almaslamani, 2021, medRxiv.

Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild-to-moderate SARS-CoV-2 in Qatar

L. Abu-Raddad, R. Bertollini, A. Butt, 2022, International Journal of Infectious Diseases.

Favipiravir for the treatment of coronavirus disease 2019 pneumonia; a propensity score-matched cohort study

A. Omrani, M. Almaslamani, A. Alkhal, 2022, Journal of Infection and Public Health.

Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar

N. Asaad, A. Butt, A. Al-khal, 2023, Nature Communications.